APA-referens

Rinciog, C., Diamantopoulos, A., Gentilini, A., Bondue, B., Dahlqvist, C., Froidure, A., . . . Soulard, S. (2020). Cost-Effectiveness Analysis of Nintedanib Versus Pirfenidone in Idiopathic Pulmonary Fibrosis in Belgium. Pharmacoecon Open.

Chicago-stil citat

Rinciog, C., A. Diamantopoulos, A. Gentilini, B. Bondue, C. Dahlqvist, A. Froidure, W. A. Wuyts, och S. Soulard. "Cost-Effectiveness Analysis of Nintedanib Versus Pirfenidone in Idiopathic Pulmonary Fibrosis in Belgium." Pharmacoecon Open 2020.

MLA-referens

Rinciog, C., et al. "Cost-Effectiveness Analysis of Nintedanib Versus Pirfenidone in Idiopathic Pulmonary Fibrosis in Belgium." Pharmacoecon Open 2020.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.